Abundant sialylated HMO
3'SL (3´Sialyllactose Sodium Salt) is an abundant sialylated HMO in human milk. Some primary known benefits of 3'SL include reducing infection by inhibiting the adhesion of pathogenic bacteria and their toxins. Also, 3'SL can positively support brain development by affecting cognition and regulating neurons.
Regulatory filings for 3'SL have been made in EU and US and preparation is on way for other major markets.
GlyCare™ 3SL will be commercially available in all application areas outside infant formula from 2020.